Some of the material in is restricted to members of the community. By logging in, you may be able to gain additional access to certain collections or items. If you have questions about access or logging in, please use the form on the Contact Page.
ROC curves are often used to evaluate predictive accuracy of statistical prediction models. This thesis studies other measures which not only incorporate the statistical but also the clinical consequences of using a particular prediction model. Depending on the disease and population under study, the mis-classification costs of false positives and false negatives vary. The concept of Decision Curve Analysis (DCA) takes this cost into account, by using the threshold probability (the probability above which a patient opts for treatment). Using the DCA technique, a Net Benefit Curve is built by plotting "Net Benefit", a function of the expected benefit and expected harm of using a model, by the threshold probability. Only the threshold probability range that is relevant to the disease and the population under study is used to plot the net benefit curve to obtain the optimum results using a particular statistical model. This thesis concentrates on the process of construction of a summary measure to find which predictive model yields highest net benefit. The most intuitive approach is to calculate the area under the net benefit curve. We examined whether the use of weights such as, the estimated empirical distribution of the threshold probability to compute the weighted area under the curve, creates a better summary measure. Real data from multiple cardiovascular research studies- The Diverse Population Collaboration (DPC) datasets, is used to compute the summary measures: area under the ROC curve (AUROC), area under the net benefit curve (ANBC) and weighted area under the net benefit curve (WANBC). The results from the analysis are used to compare these measures to examine whether these measures are in agreement with each other and which would be the best to use in specified clinical scenarios. For different models the summary measures and its standard errors (SE) were calculated to study the variability in the measure. The method of meta-analysis is used to summarize these estimated summary measures to reveal if there is significant variability among these studies.